Ozempic vs Soliqua

Drug comparison

Last updated 2026-05-28 15:46 UTC

Ozempic (semaglutide by Novo Nordisk) and Soliqua (lixisenatide by Sanofi) are both injectable medications for type 2 diabetes, but Ozempic is also approved to reduce cardiovascular risk and treat chronic kidney disease. Both are taken as shots under the skin, but Ozempic is given once weekly while Soliqua is taken once daily. Ozempic contains semaglutide, while Soliqua combines lixisenatide with insulin glargine.

AI summary of the sources below.

	Ozempic	Soliqua
Active ingredient	semaglutide	lixisenatide
Manufacturer	novo-nordisk	sanofi
Route	subcutaneous injection	subcutaneous injection
FDA-approved for	type 2 diabetes, cardiovascular risk reduction, chronic kidney disease	type 2 diabetes
Label updated	2026-01-30	2026-03-18

Compare full details on the Ozempic and Soliqua pages.